Pyrazole → HCID 67004648, Verbindung

HRID 217141

Reaktionsgleichung

Reaktionsgleichung von HRID 217141
[H-].[Na+].[NH:3]1[CH:7]=[CH:6][CH:5]=[N:4]1.[Br:8][C:9]1[CH:10]=[C:11](F)[C:12]([N+:16]([O-:18])=[O:17])=[C:13]([F:15])[CH:14]=1>C1COCC1>[Br:8][C:9]1[CH:14]=[C:13]([F:15])[C:12]([N+:16]([O-:18])=[O:17])=[C:11]([N:3]2[CH:7]=[CH:6][CH:5]=[N:4]2)[CH:10]=1

Komponenten

5

Reaktionsbedingungen

Temperatur
0 °C

Versuchsvorschrift

To a suspension of sodium hydride (44 mg, 1.1 mmol, 60% oil dispersion) in THF (4 mL), stirred at 0° C., was added a solution of pyrazole (72 mg, 1.05 mmol) in THF (1 mL). The resulting mixture was stirred at 0° C. for 5 minutes and a solution of 5-bromo-1,3-difluoro-2-nitro-benzene (238 mg, 1 mmol) in THF (1 mL) was added. The mixture was stirred at room temperature for 1 hour, quenched by addition of water (1 mL), then partitioned between water (20 mL) and ethyl acetate (50 mL). The organic layer was washed with brine, dried (MgSO4), and concentrated in vacuo. The residue was purified by column chromatography over silica gel eluted with ethyl acetate:hexanes (1:6), to afford 240 mg (86%) of the title compound. 1H NMR (CDCl3) δ 6.55 (t, 1H), 7.45 (d, 1H), 7.60 (s, 1H), 7.80 (m, 2H). MS M+1 287, M+1+2 289.

Aufarbeitung

  1. stirringThe resulting mixture was stirred at 0° C. for 5 minutes
  2. stirringThe mixture was stirred at room temperature for 1 hour
  3. customquenched by addition of water (1 mL)
  4. custompartitioned between water (20 mL) and ethyl acetate (50 mL)
  5. washThe organic layer was washed with brine
  6. dry with materialdried (MgSO4)
  7. concentrationconcentrated in vacuo
  8. customThe residue was purified by column chromatography over silica gel
  9. washeluted with ethyl acetate:hexanes (1:6)

Quellen und Nachweise

ORD-Eintrag
ord-18cf073f84af497e87c3739ab11ab8f0
Quelldatensatz
uspto-grants-2012_06
Patentnummer
US08193352B2

Verknüpfte Notizen

Wird geladen…